Clinical Trial Update: Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC [Phase 2, Phase 3]

View source ↗

Summary

This completed Phase 2/3 study compares paclitaxel plus capecitabine to docetaxel plus capecitabine in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Norwegian Breast Cancer Group | Conditions: Breast Neoplasm | Phase 2, Phase 3 | Status: COMPLETED